PRECLINICAL AND HUMAN CORRELATIVE STUDIES OF A NOVEL BRUTON TYROSINE KINASE INHIBITOR IN PANCREATIC CANCER

The Univeristy Of Texas M.D. Anderson Cancer Center

Investigators